Test Price
4,000 AED✅ Home Collection Available
Lung Cancer Panel 6 (EGFR Sequencing, ALK IHC, ROS1 FISH) in UAE | 4000 AED | 2026 DHA Guidelines
تحليل فحص سرطان الرئة الشامل 6 (EGFR, ALK, ROS1) في الإمارات | 4000 درهم | معتمد من هيئة الصحة بدبي
✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) accredited processing. All mutations validated with orthogonal methods.
✔ Premium Logistics: Paid Hospital‑Grade Home Collection with Cold‑Chain Courier & VIP Mobile Phlebotomy (8 AM‑11 PM). Sampled closed within 60 minutes, transported at 2‑8 °C.
✔ Clinical Guidance: Telephonic Post‑Test Clinical Guidance with our DHA‑licensed oncologists to interpret results and coordinate next steps.
✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – all major UAE insurers accepted.
ملخص تنفيذي للمريض: نقدم دقة تشخيصية بنسبة 99.9% مع جمع عينات منزلي معتمد وخدمات دفع التأمين المباشر عبر واتساب، وفقاً للمعايير الاماراتية وارشادات هيئة الصحة بدبي 2026.
Overview of the Lung Cancer Panel 6
The Lung Cancer Panel 6 is a comprehensive molecular assay that simultaneously assesses EGFR mutations by Sanger Sequencing, ALK rearrangements by IHC, and ROS1 fusions by FISH from FFPE tumor tissue. This single‑visit, 5‑7 day panel provides oncologists with the actionable biomarkers required to select first‑line targeted therapy, avoiding chemotherapy in eligible patients.
| Parameter | Our Test – Lung Cancer Panel 6 | Closest Alternative (NGS Multigene Panel) |
|---|---|---|
| Precision | >99% sensitivity for EGFR, ALK, ROS1; each method validated individually | Broad NGS often misses ALK fusions; may require orthogonal IHC confirmation |
| Method | Sanger Sequencing (EGFR) + IHC (ALK) + FISH (ROS1) – gold‑standard for fusion detection | DNA‑based NGS alone, limited RNA fusion detection unless ordered as separate RNA NGS |
| Turnaround Time | 5‑7 working days | Typically 10‑14 working days (with reflex testing) |
| Cost‑Effectiveness | 4000 AED fixed price, insurance‑covered; no hidden charges | Often >5500 AED with additional IHC/FISH add‑ons |
Physician Insight & Safety Protocol
“As an oncologist registered with the DHA, I understand the weight a lung cancer diagnosis carries. This panel isn't just a test—it’s a roadmap. However, a molecular result is only one piece of the clinical picture; always discuss your full history and imaging findings with me to ensure the safest therapeutic path.”
— Dr. Prabhakar Reddy, DHA Medical License 61713011, Consultant Oncology
⚠ Do not discontinue prescribed medication without consulting your doctor. Biomarker results must be interpreted within the complete clinical context.
Exclusion Criteria & Emergency Red Flags
- Not for patients without a confirmed histological diagnosis of primary non‑small cell lung carcinoma (NSCLC).
- Insufficient tumor cellularity (<20% tumor nuclei) may yield false‑negative; repeat biopsy required.
- Liquid biopsy (ctDNA) is not a substitute for tissue testing in this panel—only FFPE tumor tissue accepted.
- Testing during active chemotherapy may alter protein expression (ALK IHC); ideally test on pre‑treatment archival tissue.
🚨 Seek immediate emergency care if you experience severe dyspnea, massive hemoptysis, acute chest pain, or signs of superior vena cava syndrome while awaiting results.
Patient FAQ & Clinical Guidance
Q: Why do I need the Lung Cancer Panel 6?
The panel detects EGFR, ALK, and ROS1 mutations that directly determine eligibility for targeted oral therapies, often minimizing chemotherapy. Without these results, your oncologist cannot prescribe the most effective, least toxic precision medicine for your specific lung cancer subtype.
يكشف هذا الفحص عن طفرات EGFR و ALK و ROS1 التي تحدد أهليتك للعلاجات الموجهة الفموية، مما يقلل الحاجة للعلاج الكيميائي ويوفر خطة علاج دقيقة مصممة خصيصاً لحالتك.
Q: How do I prepare for the tissue collection?
You need no fasting; the sample is a tumor tissue biopsy typically obtained during a previous bronchoscopy or CT‑guided biopsy procedure. Our home collection service arranges safe pickup of your already‑collected FFPE block or slides from the hospital’s pathology lab.
لا تحتاج إلى صيام؛ العينة هي نسيج ورمي تم الحصول عليه مسبقاً أثناء تنظير القصبات أو خزعة موجهة. خدمتنا تقوم بجمع القالب النسيجي من مختبر المستشفى مباشرة.
Q: How long will results take and how are they explained?
Results are reported in 5‑7 working days with a full molecular interpretation and therapy guidance signed by a consultant pathologist. Our DHA‑licensed oncologist will call you to explain the report, answer questions, and coordinate the next oncology consultation.
تظهر النتائج خلال 5‑7 أيام عمل مع تقرير جزيئي كامل وارشادات علاجية موقعة من استشاري علم الأمراض. سيتصل بك طبيب الأورام المعتمد لتفسير النتائج وتنسيق الخطوات التالية.
Federally compliant with Decree‑Law No. 41 of 2024, CDS Law 2026 (Minor Data Privacy) & UAE PDPL. All laboratory operations are conducted under ISO 9001:2015 certification. Laboratory facility license: 9834453.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians